Search Results - "Montilla‐Morales, Carlos A."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases by Atienza‐Mateo, Belén, Martín‐Varillas, José Luis, Calvo‐Río, Vanesa, Demetrio‐Pablo, Rosalía, Beltrán, Emma, Sánchez‐Bursón, Juan, Mesquida, Marina, Adan, Alfredo, Hernández, María Victoria, Hernández‐Garfella, Marisa, Valls‐Pascual, Elia, Martínez‐Costa, Lucía, Sellas‐Fernández, Agustí, Cordero‐Coma, Miguel, Díaz‐Llopis, Manuel, Gallego, Roberto, García‐Serrano, José L., Ortego‐Centeno, Norberto, Herreras, José M., Fonollosa, Alejandro, Garcia‐Aparicio, Ángel M., Maíz‐Alonso, Olga, Blanco, Ana, Torre‐Salaberri, Ignacio, Fernandez‐Espartero, Cruz, Jovaní, Vega, Peiteado, Diana, Pato, Esperanza, Cruz, Juan, Férnandez‐Cid, Carlos, Aurrecoechea, Elena, García‐Arias, Miriam, Castañeda, Santos, Caracuel‐Ruiz, Miguel A., MontillaMorales, Carlos A., Atanes‐Sandoval, Antonio, Francisco, Félix, Insua, Santos, González‐Suárez, Senen, Sanchez‐Andrade, Amalia, Gamero, Fernando, Linares Ferrando, Luis F., Romero‐Bueno, F., García‐González, A. Javier, González, Raquel Almodóvar, Muro, Enrique Minguez, Carrasco‐Cubero, Carmen, Olive, Alejandro, Prior, Águeda, Vázquez, Julio, Ruiz‐Moreno, Oscar, Jiménez‐Zorzo, Fernando, Manero, Javier, Muñoz Fernandez, Santiago, Fernández‐Carballido, Cristina, Rubio‐Romero, Esteban, Pages, Fred Antón, Toyos‐Sáenz de Miera, Francisco J., Martinez, Myriam Gandia, Díaz‐Valle, David, López Longo, Francisco J., Nolla, Joan M., Álvarez, Enrique Raya, Martínez, Marcelino Revenga, González‐López, Julio José, Rodríguez‐Cundin, Paz, Hernández, José L., González‐Gay, Miguel A., Blanco, Ricardo

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-12-2019)
    “…Objective To compare the efficacy of infliximab (IFX) versus adalimumab (ADA) as a first‐line biologic drug over 1 year of treatment in a large series of…”
    Get full text
    Journal Article
  2. 2
  3. 3